Ella J. Daly, MD

Field-Based Medical Affairs, Janssen Scientific Affairs, LLC, Titusville, New Jersey; Drs Williamson and Daly and Mr Manera were affiliated with Janssen Scientific Affairs, LLC, at the time the trial was conducted.

JCP
Esketamine Nasal Spray and Adverse Events Over Time
Original Research

September 19, 2022

This study looked at the occurrence and severity of adverse events over time with esketamine nasal spray in MDD patients also receiving an oral antidepressant.
David J. Williamson, Jagadish P. Gogate, Jennifer K. Kern Sliwa, et al
JCP
Original Research

April 28, 2020

Read a study about esketamine nasal spray (oral antidepressant) and it's long-term safety, tolerability, and efficacy for treatment-resistant depression (TRD).
Ewa Wajs, Leah Aluisio, Richard Holder, et al
PCC
Original Research

August 19, 2009

Benji T. Kurian, Madhukar H. Trivedi, Bruce D. Grannemann, et al

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe